-
Neurodegenerative tauopathies.
Annu Rev Neurosci. 2001;24:1121-59
PMID: 11520930
-
Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions.
Neuron. 2001 Apr;30(1):135-47
PMID: 11343650
-
Elevated levels of DeltaFosB and RGS9 in striatum in Parkinson's disease.
Biol Psychiatry. 2001 Nov 15;50(10):813-6
PMID: 11720701
-
Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy.
Neurology. 2002 Feb 26;58(4):589-92
PMID: 11865137
-
D1 dopamine receptor regulation of microtubule-associated protein-2 phosphorylation in developing cerebral cortical neurons.
J Neurosci. 2002 Jul 15;22(14):6092-105
PMID: 12122070
-
Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis.
J Neurosci. 2002 Oct 15;22(20):8951-60
PMID: 12388602
-
Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease.
J Neurosci. 2002 Nov 15;22(22):9733-41
PMID: 12427828
-
Monoamine transporters: from genes to behavior.
Annu Rev Pharmacol Toxicol. 2003;43:261-84
PMID: 12359863
-
Loss of striatal neurons in Parkinson's disease: a cytometric study.
Eur Neurol. 1980;19(5):339-44
PMID: 7398694
-
DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization.
J Neurosci. 1984 Jan;4(1):111-24
PMID: 6319625
-
Substantia nigra lesion protects against ischemic damage in the striatum.
Neurosci Lett. 1987 Oct 5;80(3):251-6
PMID: 3120058
-
Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease.
Brain Res. 1988 Jul 5;455(1):148-52
PMID: 3416180
-
Excitotoxicity of NMDA and kainic acid is modulated by nigrostriatal dopaminergic fibres.
Neurosci Lett. 1989 Dec 15;107(1-3):256-60
PMID: 2515501
-
SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat.
Cell. 1995 Sep 22;82(6):937-48
PMID: 7553854
-
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter.
Nature. 1996 Feb 15;379(6566):606-12
PMID: 8628395
-
Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections.
Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):1956-61
PMID: 8700866
-
Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum.
J Comp Neurol. 1996 Oct 7;374(1):70-83
PMID: 8891947
-
Neurotoxicity of amphetamines and their metabolites.
NIDA Res Monogr. 1997;173:128-45
PMID: 9260187
-
Reactive astrocytes: cellular and molecular cues to biological function.
Trends Neurosci. 1997 Dec;20(12):570-7
PMID: 9416670
-
Profound neuronal plasticity in response to inactivation of the dopamine transporter.
Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):4029-34
PMID: 9520487
-
Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor.
J Neurochem. 1998 Jun;70(6):2406-15
PMID: 9603205
-
Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter.
J Neurosci. 1998 Jul 1;18(13):4861-9
PMID: 9634552
-
Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis.
Brain Res Brain Res Rev. 1998 May;26(2-3):148-53
PMID: 9651511
-
Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA.
Nat Genet. 1998 Oct;20(2):198-202
PMID: 9771716
-
Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease.
J Neurosci. 1998 Dec 1;18(23):10116-27
PMID: 9822765
-
Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity.
Science. 1999 Jan 15;283(5400):397-401
PMID: 9888856
-
Choreoathetoid movements in cocaine dependence.
Biol Psychiatry. 1999 Jun 15;45(12):1630-5
PMID: 10376125
-
DeltaFosB: a molecular mediator of long-term neural and behavioral plasticity.
Brain Res. 1999 Jul 17;835(1):10-7
PMID: 10448191
-
Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter.
Eur J Neurosci. 1999 Oct;11(10):3499-511
PMID: 10564358
-
Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.
Nature. 1999 Dec 9;402(6762):615-22
PMID: 10604467
-
Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.
Cell. 2000 Mar 31;101(1):57-66
PMID: 10778856
-
Neuronal cell death in Huntington's disease: a potential role for dopamine.
Trends Neurosci. 2000 Jun;23(6):239-45
PMID: 10838590
-
Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice.
Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6809-14
PMID: 10829080
-
Release and elimination of dopamine in vivo in mice lacking the dopamine transporter: functional consequences.
Eur J Neurosci. 2000 Aug;12(8):2985-92
PMID: 10971639
-
Dopamine-receptor stimulation: biobehavioral and biochemical consequences.
Trends Neurosci. 2000 Oct;23(10 Suppl):S92-100
PMID: 11052226
-
Antipsychotic treatment induces alterations in dendrite- and spine-associated proteins in dopamine-rich areas of the primate cerebral cortex.
Biol Psychiatry. 2001 Jan 1;49(1):1-12
PMID: 11163774
-
Coexpression of human cdk5 and its activator p35 with human protein tau in neurons in brain of triple transgenic mice.
Neurobiol Dis. 2001 Feb;8(1):32-44
PMID: 11162238
-
Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5.
Nature. 2001 Mar 15;410(6826):376-80
PMID: 11268215
-
Cocaine-induced persistent dyskinesias.
Neurology. 2001 Apr 10;56(7):964-5
PMID: 11294937
-
A decade of CDK5.
Nat Rev Mol Cell Biol. 2001 Oct;2(10):749-59
PMID: 11584302